vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $71.1M, roughly 1.1× RE/MAX Holdings, Inc.). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -9.6%, a 11.6% gap on every dollar of revenue. On growth, RE/MAX Holdings, Inc. posted the faster year-over-year revenue change (-1.8% vs -16.8%). Over the past eight quarters, RE/MAX Holdings, Inc.'s revenue compounded faster (-4.7% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
BIOX vs RMAX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $71.1M |
| Net Profit | $-7.4M | $1.4M |
| Gross Margin | 46.8% | — |
| Operating Margin | 9.3% | 13.1% |
| Net Margin | -9.6% | 2.0% |
| Revenue YoY | -16.8% | -1.8% |
| Net Profit YoY | -20.2% | -75.2% |
| EPS (diluted) | $-0.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $71.1M | ||
| Q3 25 | $77.6M | $73.2M | ||
| Q2 25 | — | $72.8M | ||
| Q1 25 | $60.6M | $74.5M | ||
| Q4 24 | $98.8M | $72.5M | ||
| Q3 24 | $93.3M | $78.5M | ||
| Q2 24 | — | $78.5M | ||
| Q1 24 | $84.0M | $78.3M |
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-7.4M | $4.0M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | $-1.6M | $-2.0M | ||
| Q4 24 | $605.2K | $5.8M | ||
| Q3 24 | $-6.2M | $966.0K | ||
| Q2 24 | — | $3.7M | ||
| Q1 24 | $9.8M | $-3.4M |
| Q4 25 | — | — | ||
| Q3 25 | 46.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 50.8% | — |
| Q4 25 | — | 13.1% | ||
| Q3 25 | 9.3% | 25.0% | ||
| Q2 25 | — | 19.3% | ||
| Q1 25 | 1.5% | 7.2% | ||
| Q4 24 | 14.5% | 5.9% | ||
| Q3 24 | 2.5% | 19.4% | ||
| Q2 24 | — | 20.6% | ||
| Q1 24 | 15.7% | 5.8% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | -9.6% | 5.4% | ||
| Q2 25 | — | 6.4% | ||
| Q1 25 | -2.6% | -2.6% | ||
| Q4 24 | 0.6% | 8.0% | ||
| Q3 24 | -6.6% | 1.2% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | 11.6% | -4.3% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.12 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $0.14 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $118.7M |
| Total DebtLower is stronger | — | $432.2M |
| Stockholders' EquityBook value | $288.3M | $452.4M |
| Total Assets | $734.9M | $582.5M |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $118.7M | ||
| Q3 25 | $15.5M | $107.5M | ||
| Q2 25 | — | $94.3M | ||
| Q1 25 | $38.5M | $89.1M | ||
| Q4 24 | $29.2M | $96.6M | ||
| Q3 24 | $32.3M | $83.8M | ||
| Q2 24 | — | $66.1M | ||
| Q1 24 | $16.4M | $82.1M |
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
| Q4 25 | — | $452.4M | ||
| Q3 25 | $288.3M | $448.1M | ||
| Q2 25 | — | $442.4M | ||
| Q1 25 | $345.0M | $433.5M | ||
| Q4 24 | $346.3M | $429.5M | ||
| Q3 24 | $346.0M | $423.1M | ||
| Q2 24 | — | $418.4M | ||
| Q1 24 | $348.5M | $412.0M |
| Q4 25 | — | $582.5M | ||
| Q3 25 | $734.9M | $582.2M | ||
| Q2 25 | — | $574.8M | ||
| Q1 25 | $798.2M | $571.4M | ||
| Q4 24 | $835.2M | $581.6M | ||
| Q3 24 | $827.3M | $578.6M | ||
| Q2 24 | — | $571.4M | ||
| Q1 24 | $836.1M | $566.7M |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $40.9M |
| Free Cash FlowOCF − Capex | — | $33.5M |
| FCF MarginFCF / Revenue | — | 47.1% |
| Capex IntensityCapex / Revenue | — | 10.4% |
| Cash ConversionOCF / Net Profit | — | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.9M | ||
| Q3 25 | $14.4M | $17.7M | ||
| Q2 25 | — | $4.6M | ||
| Q1 25 | $23.3M | $5.7M | ||
| Q4 24 | $-5.4M | $59.7M | ||
| Q3 24 | $5.2M | $17.6M | ||
| Q2 24 | — | $15.9M | ||
| Q1 24 | $-17.4M | $9.4M |
| Q4 25 | — | $33.5M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $4.0M | ||
| Q4 24 | — | $53.0M | ||
| Q3 24 | — | $16.3M | ||
| Q2 24 | — | $14.0M | ||
| Q1 24 | — | $6.8M |
| Q4 25 | — | 47.1% | ||
| Q3 25 | — | 22.4% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 73.2% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 17.8% | ||
| Q1 24 | — | 8.6% |
| Q4 25 | — | 10.4% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | — | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | -1.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
